http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009537595-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2007-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009537595-A |
| titleOfInvention | Piperidine derivatives as human papillomavirus inhibitors |
| abstract | Formula (I) wherein G 1 represents a hydrocarbon bond or a chain optionally substituted by one or two alkyl groups, G 2 represents a group (see Formula Ia + Ib), or R is Represents hydrogen, alkyl, halogenoalkyl, or a prodrug group such as carbamate, acetyl or dialkylaminomethyl, G represents a hydrocarbon chain optionally substituted by a bond or one or two alkyl groups, and W is Represents oxygen or sulfur, wherein R 1 and R 2 are each selected from hydrogen, halogen, hydroxyl, thio, alkoxy, halogenoalkoxy, alkylthio, halogenoalkylthio, amino, monoalkylamino, dialkylamino, cycloalkyl, alkyl or halogenoalkyl represents a group, R 3 is an acid or acid functional Purodora' Represents a group or acid functional bioequivalent, A represents an aryl, cycloalkyl, cycloalkenyl or heterocycle, each optionally substituted, and B has 6 chains, each HPV inhibitors and pharmaceutically acceptable salts having an optionally substituted aryl or heterocycle. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016503068-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015522529-A |
| priorityDate | 2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 413.